enasidenib
bms,servier
['leusm', 'leukemia', 'idhentify', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'enasidenib']
congress #asco22 | st phane de botton reports on the idhentify phase iii trial of pts with idh2mut r/r aml treated with enasidenib or ccr. n=319. median os in the r172 subgroup was 14.6 mo with ena vs 7.8 mo with ccr. #leusm #leukemia 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm